omega-3-acid ethyl esters 90 (TAK-085)

DRUG2 trials

Sponsors

Takeda

Conditions

Hypertriglyceridemia

Phase 3

Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia

CompletedNCT01350999

TakedaHypertriglyceridemia

Start: 2009-11-30End: 2011-01-31Updated: 2016-09-20

Efficacy of TAK-085 in Participants With Hypertriglyceridemia

CompletedNCT01350973

TakedaHypertriglyceridemia

Start: 2009-11-30End: 2010-12-31Updated: 2016-09-20